A Comparison for Type 2 Cytokines and Lesional Inflammatory Infiltrations in Bullous Pemphigoid and Atopic Dermatitis

被引:9
作者
Hu, Yu-qing [1 ]
Zhang, Jian-zhong [1 ]
机构
[1] Peking Univ, Dept Dermatol, Peoples Hosp, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
type; 2; immunity; thymic stromal lymphopoietin; bullous pemphigoid; atopic dermatitis; Th2; cytokines; inflammatory infiltrations; THYMIC STROMAL LYMPHOPOIETIN; LANGERHANS CELLS; TSLP; IGE; MECHANISMS; CRITERIA; DISEASE;
D O I
10.2147/CCID.S376845
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Bullous pemphigoid (BP) and atopic dermatitis (AD) are both type 2 inflammatory skin diseases with similar clinical features. Thymic stromal lymphopoietin (TSLP) is an epithelial-derived cytokine which is upregulated in AD. However, the expression of TSLP in BP and the correlation between TSLP and inflammatory infiltrations have not been fully studied.Objective: To characterize the serum Th2 cytokines level and Th2 inflammatory cell infiltrations in BP and AD. To study TSLP levels in serum, blister fluids and expression in lesional skin in patients with BP and AD.Methods: TSLP level in serum and blister fluids was measured by enzyme-linked immunosorbent assay (ELISA). Inflammatory cells (CD4+ T cells, CD8+ T cells, CD1a+ cells, eosinophils and mast cells) were stained immunohistochemically and quantified by image analysis.Results: TSLP level was significantly increased in blister fluids of BP and was highly expressed in lesional skin of BP and AD. Serum levels of IL-6, IL-4, IL-22, IFN-gamma and thymic activation regulates chemokines (TARC) were significantly higher in patients with BP and AD than in healthy controls. CD4+ T cells, CD8+ T cells and CD1a+ cells were significantly more in upper dermis of BP and AD lesions. Eosinophils were found more in BP lesions while mast cells were found more in AD lesions than in healthy controls. A distinct correlation was found between TSLP levels and the intensities of CD4+ T cells, CD1a+ cells infiltrations.Conclusion: TSLP was significantly higher in blister fluids and skin lesions of BP, suggesting that it might contribute to the pathogenesis of BP. BP exhibited a similar type 2 immune response and a slight difference in cells infiltrations with AD.
引用
收藏
页码:2313 / 2321
页数:9
相关论文
共 31 条
[1]   Type 2 immunity in the skin and lungs [J].
Akdis, Cezmi A. ;
Arkwright, Peter D. ;
Bruggen, Marie-Charlotte ;
Busse, William ;
Gadina, Massimo ;
Guttman-Yassky, Emma ;
Kabashima, Kenji ;
Mitamura, Yasutaka ;
Vian, Laura ;
Wu, Jianni ;
Palomares, Oscar .
ALLERGY, 2020, 75 (07) :1582-1605
[2]   Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV) [J].
Borradori, L. ;
Van Beek, N. ;
Feliciani, C. ;
Tedbirt, B. ;
Antiga, E. ;
Bergman, R. ;
Boeckle, B. C. ;
Caproni, M. ;
Caux, F. ;
Chandran, N. S. ;
Cianchini, G. ;
Daneshpazhooh, M. ;
De, D. ;
Didona, D. ;
Di Zenzo, G. M. ;
Dmochowski, M. ;
Drenovska, K. ;
Ehrchen, J. ;
Goebeler, M. ;
Groves, R. ;
Guenther, C. ;
Horvath, B. ;
Hertl, M. ;
Hofmann, S. ;
Ioannides, D. ;
Itzlinger-Monshi, B. ;
Jedlickova, J. ;
Kowalewski, C. ;
Kridin, K. ;
Lim, Y. L. ;
Marinovic, B. ;
Marzano, A. ;
Mascaro, J. -M. ;
Meijer, J. M. ;
Murrell, D. ;
Patsatsi, K. ;
Pincelli, C. ;
Prost, C. ;
Rappersberger, K. ;
Sardy, M. ;
Setterfield, J. ;
Shahid, M. ;
Sprecher, E. ;
Tasanen, K. ;
Uzun, S. ;
Vassileva, S. ;
Vestergaard, K. ;
Vorobyev, A. ;
Vujic, I. ;
Wang, G. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (10) :1689-1704
[3]   The importance of TSLP in allergic disease and its role as a potential therapeutic target [J].
Cianferoni, Antonella ;
Spergel, Jonathan .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (11) :1463-1474
[4]   New Treatments for Atopic Dermatitis Targeting Skin Barrier Repair via the Regulation of FLG Expression [J].
Debinska, Anna .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
[5]  
EMTESTAM L, 1987, ACTA DERM-VENEREOL, V67, P529
[6]   Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies [J].
Furue, Masutaka ;
Chiba, Takahito ;
Tsuji, Gaku ;
Ulzii, Dugarmaa ;
Kido-Nakahara, Makiko ;
Nakahara, Takeshi ;
Kadono, Takafumi .
ALLERGOLOGY INTERNATIONAL, 2017, 66 (03) :398-403
[7]   Pruritus as a Distinctive Feature of Type 2 Inflammation [J].
Garcovich, Simone ;
Maurelli, Martina ;
Gisondi, Paolo ;
Peris, Ketty ;
Yosipovitch, Gil ;
Girolomoni, Giampiero .
VACCINES, 2021, 9 (03)
[8]   Biomarkers related to bullous pemphigoid activity and outcome [J].
Giusti, Delphine ;
Le Jan, Sebastien ;
Gatouillat, Gregory ;
Bernard, Philippe ;
Pham, Bach Nga ;
Antonicelli, Frank .
EXPERIMENTAL DERMATOLOGY, 2017, 26 (12) :1240-1247
[9]   Pemphigus autoimmunity: Hypotheses and realities [J].
Grando, Sergei A. .
AUTOIMMUNITY, 2012, 45 (01) :7-35
[10]   Mechanisms of Disease: Pemphigus and Bullous Pemphigoid [J].
Hammers, Christoph M. ;
Stanley, John R. .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11, 2016, 11 :175-197